Beam Therapeutics Inc. (BEAM)
undefined
undefined%
At close: undefined
28.00
0.32%
After-hours Dec 13, 2024, 04:29 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -132.53M -289.09M -370.64M -194.59M -78.33M -116.74M -8.00M
Depreciation & Amortization 20.01M 14.15M 7.45M 4.74M 3.50M 650.00K 11.00K
Stock-Based Compensation 98.65M 84.32M 43.57M 15.38M 7.03M 7.00M 198.00K
Other Working Capital -108.88M 249.25M 110.44M 5.29M -14.80M 7.64M 14.00K
Other Non-Cash Items -18.87M -38.48M 158.86M 9.87M 2.02M 66.96M 3.85M
Deferred Income Tax - - -16.77M 63.52M 4.48M 11.75M 500.00K
Change in Working Capital -116.45M 251.63M 111.25M 5.35M -10.71M 10.07M 740.00K
Operating Cash Flow -149.19M 22.53M -66.27M -95.74M -72.00M -20.30M -2.71M
Capital Expenditures -33.73M -48.95M -46.81M -16.36M -12.52M -13.12M -346.00K
Acquisitions - 412.38M 620.00K 83.77M 54.14M - -
Purchase of Investments -984.34M -1.62B -777.22M -282.36M -130.21M -300.00K -
Sales Maturities Of Investments 1.09B 1.20B 529.27M 198.60M 76.07M - -
Other Investing Acitivies - -412.38M -247.95M -83.77M -54.14M -300.00K -
Investing Cash Flow 71.84M -461.34M -294.14M -100.12M -66.66M -13.42M -346.00K
Debt Repayment -2.25M -2.29M -2.12M 1.70M 5.71M - -
Common Stock Repurchased - - - - -25.19M - -
Dividend Paid - - - - -12.71M - -
Other Financial Acitivies 8.53M 5.62M 810.00K 1.10M 48.28M 179.73M 4.98M
Financial Cash Flow 276.45M 111.59M 756.14M 322.32M 41.28M 179.73M 4.98M
Net Cash Flow 199.09M -327.22M 395.73M 126.46M -97.38M 146.00M 1.93M
Free Cash Flow -182.93M -26.42M -113.08M -112.10M -84.52M -33.42M -3.05M